Clinical Results of Carbon Ion Radiotherapy at NIRS.

In 1994 a Phase I/II clinical study on carbon ion radiotherapy was begun at NIRS using HIMAC, which was then the world's only heavy ion accelerator complex dedicated to medical use in a hospital environment. Among several types of ion species, we have chosen carbon ions for cancer therapy because they had the most optimal properties in terms of possessing, both physically and biologically, the most effective dose-localization in the body. The purpose of the clinical study was to investigate the efficacy of carbon ion radiotherapy against a variety of tumors as well as to develop effective techniques for delivering an efficient dose to the tumor. The RBE of carbon ions was estimated to be 2.0 to 3.0 along the SOBP for acute skin reactions. As of August 2006, a total of 2,867 patients had been entered into Phase I/II or Phase II studies and analyzed for toxicity and local tumor response. The results have shown that carbon ion radiotherapy has the potential ability to provide a sufficient dose to the tumor with acceptable morbidity in the surrounding normal tissues. Tumors that appear to respond favorably to carbon ions include locally advanced tumors and those with histologically non-squamous cell type of tumors such as adenocarcinoma, adenoid cystic carcinoma, malignant melanoma, hepatoma, and bone/soft tissue sarcoma. By taking advantage of the biological and physical properties of high-LET radiation, the efficacy of treatment regimens with small fractions in short treatment times has been confirmed for almost all types of tumors in carbon ion radiotherapy.

[1]  T. Phillips,et al.  Neon ion radiotherapy: results of the phase I/II clinical trial. , 1991, International journal of radiation oncology, biology, physics.

[2]  Susumu Kandatsu,et al.  Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Cox,et al.  Analysis of local recurrence rates after surgery alone for rectal cancer , 2004, International Journal of Colorectal Disease.

[4]  H. Akaza,et al.  Phase I/II clinical trials of carbon ion therapy for prostate cancer , 2004, The Prostate.

[5]  S Minohara,et al.  Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[6]  Susumu Kandatsu,et al.  Carbon ion radiotherapy for stage I non-small cell lung cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  H. Tsujii,et al.  Carbon Ion Radiotherapy for Unresectable Sacral Chordomas , 2004, Clinical Cancer Research.

[8]  Tatsuaki Kanai,et al.  Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  H. Tsujii,et al.  Medical and other applications of high-energy heavy-ion beams from HIMAC , 1997 .

[10]  J. Munzenrider,et al.  Proton therapy for tumors of the skull base , 1999, Strahlentherapie und Onkologie.

[11]  N. Takai,et al.  Significance of fractionated irradiation for the biological therapeutic gain of carbon ions. , 2002, Radiation protection dosimetry.

[12]  H. Tsujii.  Preliminary results of Phase I/II carbon-ion therapy , 1997 .

[13]  H. Ishikawa,et al.  Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[14]  M Raju,et al.  Heavy Particle Radiotherapy , 1980 .

[15]  Y. Ohnishi,et al.  Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. , 2007, International journal of radiation oncology, biology, physics.

[16]  H. Tsujii,et al.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.

[17]  H. Tsujii,et al.  Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors. , 2006, International journal of radiation oncology, biology, physics.

[18]  H. Tsujii,et al.  Experiences of carbon ion radiatiotherapy at NIRS , 2002 .

[19]  T. Nakano,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. , 2006, International journal of radiation oncology, biology, physics.

[20]  G. Chen,et al.  Heavy charged particle radiotherapy. , 1981, Annual review of biophysics and bioengineering.

[21]  T. Nakano,et al.  The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix. , 1999, The cancer journal from Scientific American.

[22]  Hans Blattmann,et al.  Tumor therapy with heavy charged particles , 2008 .

[23]  Y. Ohnishi,et al.  Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study. , 2007, International journal of radiation oncology, biology, physics.

[24]  森田 皓三,et al.  HIPLAN-A Heavy Ion Treatment Planning System at HIMAC. , 1996 .

[25]  Yoshiyuki Suzuki,et al.  Carbon Beam Therapy Overcomes the Radiation Resistance of Uterine Cervical Cancer Originating from Hypoxia , 2006, Clinical Cancer Research.

[26]  L. Mariani,et al.  Cancer of the low and middle rectum: Local and distant recurrences, and survival in 350 radically resected patients , 1996, Journal of surgical oncology.

[27]  Yoshiya Furusawa,et al.  Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. , 2005, Journal of radiation research.

[28]  Tatsuaki Kanai,et al.  Hypofractionated radiotherapy with carbon ion beams for prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[29]  T. Teshima,et al.  Particle irradiation suppresses metastatic potential of cancer cells. , 2005, Cancer research.

[30]  Riwa Kishimoto,et al.  Overview of clinical experiences on carbon ion radiotherapy at NIRS. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  H. Tsujii,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[32]  T. Obata,et al.  Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. , 2004, International journal of radiation oncology, biology, physics.

[33]  H. Tsujii,et al.  Primary sebaceous carcinoma of the lacrimal gland treated by carbon ion radiotherapy , 2003, International Journal of Clinical Oncology.

[34]  H. Tsujii,et al.  Cervical spine osteosarcoma treated with carbon-ion radiotherapy. , 2006, The Lancet. Oncology.

[35]  H. Tsujii,et al.  Four-fraction carbon ion radiotherapy for hepatocellular carcinoma: results of a phase II clinical trial. , 2004, Journal of Clinical Oncology.

[36]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.

[37]  S Minohara,et al.  Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[38]  R. Wilson.  Radiological use of fast protons. , 1946, Radiology.

[39]  J. Fowler,et al.  Predicting realistic RBE values for clinically relevant radiotherapy schedules. , 1997, International journal of radiation biology.

[40]  R. Fitzgibbons,et al.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum. , 1992, Surgery, gynecology & obstetrics.

[41]  H. Tsujii,et al.  Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion--pathological findings concerning tumor response and radiation induced lung injury in the resected organs. , 2003, Lung cancer.